Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Choosing Frontline Therapy in Metastatic Disease

February 27th 2018

Recent Advances in Pancreatic Cancer Research

February 27th 2018

Hepatocellular Carcinoma: Future Role of Immunotherapy

February 27th 2018

Optimizing Checkpoint Inhibitor Combinations in HCC

February 27th 2018

KEYNOTE-224: Improving HCC Outcomes With Pembrolizumab

February 27th 2018

Hepatocellular Carcinoma: Recent Approval of Nivolumab

February 27th 2018

Hepatocellular Carcinoma: Immunotherapy After Sorafenib

February 27th 2018

Recent Advances in the Treatment of Liver Cancer

February 27th 2018

Improving Outcomes in CRC

February 26th 2018

Progress in CRC Precision Medicine

February 26th 2018

Emerging Immunotherapy Combinations in MSS CRC

February 26th 2018

Managing Toxicities With Immunotherapy in CRC

February 26th 2018

Dosing and Side Effect Management in Metastatic CRC

February 26th 2018

Third-Line Treatment in Refractory CRC

February 26th 2018

Immunotherapy Options in Refractory CRC

February 26th 2018

Supportive Care in Metastatic CRC

February 26th 2018

Maintenance and Second-Line Decisions in CRC

February 26th 2018

Frontline Antibody Selection in Metastatic CRC

February 26th 2018

Left- Versus Right-Sided Tumors in CRC

February 26th 2018

Importance of HER2 Expression in CRC

February 26th 2018